Pros | - | 5Y returns in the top 25% of the category. 3Y returns in the top 25% of the category. Among most bought funds within the category. | ||
Cons | - | - |
INDMoney rank | - | - | ||
Category,Subcateogry | Equity,Index Funds | Equity,Index Funds | ||
Fund Age | 0 Years | 5 Years | ||
Fund Size | 29 Cr | 2563 Cr | ||
Min Investment | SIP ₹500 Lumpsum ₹500 | SIP ₹100 Lumpsum ₹100 | ||
Expense Ratio | 0.62% | 0.35% | ||
Exit Load | 1% | 0% | ||
Benchmark Index | Nifty MidSmall Healthcare Index (TRI) | Nifty Smallcap 250 TR INR |
No of Holdings | 31 | 256 | ||
Top 5 Holdings | Fortis Healthcare Ltd (9.59%) Lupin Ltd (8.77%) Laurus Labs Ltd (6.2%) Alkem Laboratories Ltd (5.8%) Aurobindo Pharma Ltd (5.75%) | Multi Commodity Exchange of India Ltd (2%) Laurus Labs Ltd (1.64%) Central Depository Services (India) Ltd (1.3%) Delhivery Ltd (1.21%) Radico Khaitan Ltd (1.13%) | ||
No of Sectors | 1 | 11 | ||
Top 3 Sectors | Health (100%) | Financial Services (20.61%) Industrial (20.52%) Health (14.96%) | ||
Equity % | 99.66% | 100.13% | ||
Debt % | - | - | ||
P/E | 38.2 | 27.45 | ||
P/B | 5.31 | 3.41 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | 2.83% | 4.28% | ||
3-Month Return | -2.98% | 0.71% | ||
6-Month Return | 8.73% | 13.54% | ||
1-Year Return | - | -0.88% | ||
3-Year Return | - | 22.83% | ||
5-Year Return | - | 28.19% |
Sharpe | - | 0.78 | ||
Alpha | - | -0.77 | ||
Beta | - | 0.99 | ||
Standard Deviation | - | 19.27 | ||
Information Ratio | - | -2.52 |
Description | Motilal Oswal Nifty MidSmall Healthcare Index Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | Nippon India Nifty Smallcap 250 Index Fund Dir Gr is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Rakesh Shetty,Swapnil Mayekar,Dishant Mehta | Himanshu Mange |